Background Amivantamab has been approved for the treatment of patients with advanced
non–small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 …

Fucoidans are natural sulfated polysaccharides that have a wide range of biological
functions and are regarded as promising antitumor agents. The activity of various fucoidans …

Background: Fluoropyrimidine is widely used owing to its clinical efficacy, however, patients
with dihydropyrimidine dehydrogenase (DPD) deficiency can experience fluoropyrimidine …

The immunosuppression and inhibition of hematopoiesis are considered to be reasons for
the development of complications after intensive chemotherapy and allogeneic …

Chemotherapy is the standard of care for most malignancies. Its tumor debulking effect in
adjuvant or neoadjuvant settings is unquestionable, although secondary effects have been …

High-risk neuroblastoma (NB) is sensitive to chemotherapy but susceptible to
chemoresistance. In this study, we aimed to analyze the incidence of chemoresistance in …

The ability to improve nanoparticle delivery to solid tumors is an actively studied domain,
where various mechanisms are looked into. In previous work, the authors have looked into …

Myelosuppression is a major adverse effect of chemotherapy. With the increasing number of
cancer patients worldwide, there is a growing interest in therapeutic approaches that reduce …

There are a diverse range of haematological malignancies with varying clinical
presentations and prognoses. Patients with haematological malignancy may require …

Purpose This phase I study was conducted to determine the maximum tolerated dose and
the recommended phase II dose of weekly administered Genexol-PM combined with …